Durvalumab plus etoposide-carboplatin for advanced digestive neuroendocrine carcinoma: a phase III trial (JCOG2107E).
CLINICAL TRIAL REGISTRATION jRCT2031230456 (https://jrct.mhlw.go.jp/latest-detail/jRCT2031230456).
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
CLINICAL TRIAL REGISTRATION jRCT2031230456 (https://jrct.mhlw.go.jp/latest-detail/jRCT2031230456).
Neuroendocrine carcinoma (NEC) of the biliary tract is an exceptionally rare and highly aggressive malignancy, and its molecular subtype landscape and diagnostic boundaries remain poorly defined. We retrospectively analyzed 42 biliary tract NECs, including 22 surgically resected cases, arising in the intrahepatic bile...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.